Nanovectorization of Prostate Cancer Treatment Strategies: A New Approach to Improved Outcomes

Prostate cancer (PC) is the most frequent male cancer in the Western world. Progression to Castration Resistant Prostate Cancer (CRPC) is a known consequence of androgen withdrawal therapy, making CRPC an end-stage disease. Combination of cytotoxic drugs and hormonal therapy/or genotherapy is a reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Omabe, Kenneth, Paris, Clément, Lannes, François, Taïeb, David, Rocchi, Palma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143094/
https://www.ncbi.nlm.nih.gov/pubmed/33919150
http://dx.doi.org/10.3390/pharmaceutics13050591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143094/
https://www.ncbi.nlm.nih.gov/pubmed/33919150
http://dx.doi.org/10.3390/pharmaceutics13050591

Ejemplares similares